Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 19;9(1):23.
doi: 10.3390/pharmacy9010023.

Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions

Hanna Justad  1 , Ylva Askfors  1 , Tero Shemeikka  1 , Marine L Andersson  2 , Tora Hammar  3
Affiliations

Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions

Hanna Justad et al. Pharmacy (Basel). .

Abstract

Janusmed interactions is a drug-drug interactions (DDI) database available online for healthcare professionals (HCP) at all levels of the healthcare system including pharmacies. The database is aimed at HCP but is also open to the public for free, for those individuals who register for a personal account. The aim of this study was to investigate why and how patients use the database Janusmed interactions, how they perceive content and usability, and how they would react if they found an interaction. A web-based questionnaire was sent by email to all users who had registered for Janusmed interactions as a "patient" (n = 3219). A total of 406 patients completed the survey (response rate 12.6%). The study shows that there is an interest among patients to use a DDI database to check their own or a relative's medication. The respondents found the database easy to use and perceive they understand the information aimed at HCP. Most patients stated they would talk to their HCP if they found an interaction and not adjust their treatment by themselves. However, the respondents in this study are actively searching for information and seem to have high health literacy. Thus, the findings are not generalizable for the general population.

Keywords: DDI; drug-drug interaction database; information needs; interaction checker; medication information; public.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. Three of the researchers (Hanna Justad, Ylva Askfors, Tero Shemeikka) are employed by Region Stockholm and work with developing the database Janusmed Interactions. One researcher (Marine L. Andersson) is working with the medical content and development of the database.

Figures

Figure 1
Figure 1
User interface Janusmed interactions (version 3.0.11) (Region Stockholm, Stockholm, Sweden)
Figure 2
Figure 2
Net Promotor Score for Janusmed interactions.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Dechanont S., Maphanta S., Butthum B., Kongkaew C. Hospital Admissions/Visits Associated with Drug-Drug Interactions: A Systematic Review and Meta-Analysis. Pharmacoepidemiol. Drug Saf. 2014;23:489–497. doi: 10.1002/pds.3592. - DOI - PubMed
    1. Avery A.J., Sheikh A., Hurwitz B., Smeaton L., Chen Y.-F., Howard R., Cantrill J., Royal S. Safer Medicines Management in Primary Care. Br. J. Gen. Pract. J. R. Coll. Gen. Pract. 2002;52:S17–S22. - PMC - PubMed
    1. Böttiger Y., Laine K., Andersson M.L., Korhonen T., Molin B., Ovesjö M.-L., Tirkkonen T., Rane A., Gustafsson L.L., Eiermann B. SFINX—A Drug-Drug Interaction Database Designed for Clinical Decision Support Systems. Eur. J. Clin. Pharmacol. 2009;65:627–633. doi: 10.1007/s00228-008-0612-5. - DOI - PubMed
    1. Lenssen R., Heidenreich A., Schulz J.B., Trautwein C., Fitzner C., Jaehde U., Eisert A. Analysis of Drug-Related Problems in Three Departments of a German University Hospital. Int. J. Clin. Pharm. 2016;38:119–126. doi: 10.1007/s11096-015-0213-1. - DOI - PubMed
    1. Neuvonen P.J., Niemi M., Backman J.T. Drug Interactions with Lipid-Lowering Drugs: Mechanisms and Clinical Relevance. Clin. Pharmacol. Ther. 2006;80:565–581. doi: 10.1016/j.clpt.2006.09.003. - DOI - PubMed

LinkOut - more resources